Rebecca Eccles's Avatar

Rebecca Eccles

@rebeccaeccles

Scientific Writer at Cancer Grand Challenges, based in London, previously Scientific Editor at Molecular Cell. Views are my own. Always happy to talk science!

51
Followers
81
Following
3
Posts
03.12.2024
Joined
Posts Following

Latest posts by Rebecca Eccles @rebeccaeccles

Post image

The new @cancergrand.bsky.social teams have been announced! Read about the teams tackling cancer avoidance, mechanisms driving mutational signatures, the dark proteome, cancer neuroscience, & rewiring cancer cells now in Cancer Discovery @aacrjournals.bsky.social: aacrjournals.org/cancerdiscov...

04.03.2026 11:59 πŸ‘ 4 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Figure 2 The dimensions of cancer
CREDIT Hanahan - Cell.

Figure 2 The dimensions of cancer CREDIT Hanahan - Cell.

An update to the Hallmarks of Cancer framework for understanding (and researching) what causes human cancers. spkl.io/63321Aqwbc

Douglas Hanahan
@cp-cell.bsky.social

29.01.2026 17:00 πŸ‘ 21 πŸ” 10 πŸ’¬ 0 πŸ“Œ 10
Post image Post image Post image

The October issue of Cancer Discovery @aacrjournals.bsky.social is now online! The cover features two papers on the role of #ecDNA heterogeneity in tumor evolution and adaptation to therapy - you can find these papers and much more here: aacrjournals.org/cancerdiscov...

06.10.2025 18:38 πŸ‘ 5 πŸ” 3 πŸ’¬ 1 πŸ“Œ 1
Preview
Boltz-2: democratising the future of drug design Open source structure prediction with binding affinity

Move over AlphaFold3. Boltz-2 has arrived, bringing affinity prediction for protein-small molecule interactions!

Can’t wait to see what this group does next. Congrats to all @gcorso.bsky.social

Was a pleasure writing this:
www.cancergrandchallenges.org/news/boltz-2...

06.06.2025 14:11 πŸ‘ 37 πŸ” 8 πŸ’¬ 1 πŸ“Œ 0
Video thumbnail

Excited to unveil Boltz-2, our new model capable not only of predicting structures but also binding affinities! Boltz-2 is the first AI model to approach the performance of FEP simulations while being more than 1000x faster! All open-sourced under MIT license! A thread… πŸ€—πŸš€

06.06.2025 13:46 πŸ‘ 215 πŸ” 91 πŸ’¬ 10 πŸ“Œ 11
Post image Post image

Come and join us! We’re hiring a new Group Leader in Generative Biology at the @sangerinstitute.bsky.social

Building AI models or the data to train them?

Core funding of >$130M a year for a faculty of ~30.

www.nature.com/naturecareer...

acrobat.adobe.com/id/urn:aaid:...

pls RT!

06.05.2025 14:59 πŸ‘ 46 πŸ” 66 πŸ’¬ 1 πŸ“Œ 0

Mariam is part of team CANCAN, who are tackling the @cancergrand.bsky.social cachexia challenge!

30.04.2025 08:04 πŸ‘ 2 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

We're hiring! The Journal of Cell Biology (JCB) seeks Scientific Editor or Senior Scientific Editor, dependent on experience. Join our team in New York City! More info πŸ‘‰ careers.rockefeller.edu/jobs?keyword...

#STEMjobs #LifeScienceJobs #PublishingJobs #ScienceJobs

29.04.2025 15:45 πŸ‘ 3 πŸ” 3 πŸ’¬ 0 πŸ“Œ 0

Hello, we are AITHYRA!
I am very excited to share with you the corporate identity of AITHYRA, the Research Institute for Biomedical AI.

Check out the brand design video (sound on!) to learn more.

**REMINDER**
One week left to apply for Starting PI positions (Life Science and AI/ML). Come join us!

28.04.2025 08:38 πŸ‘ 20 πŸ” 8 πŸ’¬ 0 πŸ“Œ 0
Preview
DFS 0161 CGC Discover mag 2024 A year of scientific creativity

The 24/25 edition of @cancergrand.bsky.social progress magazine is now live!

Including:
πŸ‘‰key advances from our funded teams
πŸ‘‰ the biggest themes in cancer research from early-onset cancers to AI and cancer as a systemic disease
πŸ‘‰our 7 new challenges

features.cancerresearchuk.org/cancergrandc...

24.04.2025 12:25 πŸ‘ 9 πŸ” 5 πŸ’¬ 0 πŸ“Œ 1